Fruticulosin: A novel type 2 ribosome-inactivating protein from Abrus fruticulosus seeds that exhibits toxic and antileishmanial activity

Archives of Biochemistry and Biophysics
Mayron Alves de VasconcelosAndré Luis Coelho da Silva

Abstract

Plant ribosome-inactivating proteins (RIPs) are a family of toxins that inhibit protein synthesis. In this study, we have isolated a novel type 2 ribosome-inactivating protein (RIP) present in seeds of the Abrus fruticulosus, named of fruticulosin. Fruticulosin, shows characteristics common to other type 2 RIPs, as specificity by galactosides (d-galactose, N-acetyl-d-galactosamine, and d-lactose), mass of approximately 60 kDa and presence of the of disulfide bonds. The N-terminal amino acid sequence (26 residues) of A-chain fruticulosin, determined by Edman degradation, revealed high similarity of the A-chain with those of other type 2 RIPs. The secondary structure of fruticulosin was analysed by circular dichroism, which showed that fruticulosin contains α-helices (22.3%), β-sheets (43.5%), and random coils and corners (34.2%). Furthermore, fruticulosin showed high toxicity in Artemia sp. (3.12 μg/mL), inhibited in vitro protein synthesis by a cell-free system and showed RNA N-glycosidase activity. Fruticulosin presented biological activities such as agglutination and antileishmanial activity on promastigote forms of Leishmania major.

References

Jan 20, 1986·FEBS Letters·F Stirpe, L Barbieri
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Jun 24, 1998·Toxicon : Official Journal of the International Society on Toxinology·M V RamosR A Moreira
Jun 28, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·W J PeumansE J Van Damme
Jun 8, 2004·Mini Reviews in Medicinal Chemistry·Maria Giulia Battelli
Aug 11, 2004·Toxicon : Official Journal of the International Society on Toxinology·Sjur Olsnes
Nov 17, 2004·Cell·Shaden KamhawiJesus G Valenzuela
May 1, 1977·Plant Physiology·R de A Moreira, J C Perrone
Jun 27, 2006·Cellular and Molecular Life Sciences : CMLS·F Stirpe, M G Battelli
Oct 6, 2006·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Raniere M MouraMaurício P Sales
Feb 20, 2007·Microbes and Infection·Jitka MyskovaPetr Volf
Mar 14, 2007·Clinics in Dermatology·Mark S Bailey, Diana N J Lockwood
Mar 21, 2007·Chemistry & Biodiversity·Daoning Zhang, Fathi T Halaweish
Apr 17, 2007·Toxicon : Official Journal of the International Society on Toxinology·Fiorenzo StirpeLuigi Barbieri
Sep 15, 2009·Current Molecular Medicine·M PuriJ R Kanwar
Nov 12, 2009·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Danielle S MedeirosElizeu A Santos
Sep 21, 2011·International Journal of Biological Macromolecules·Mrinal Kumar DasVandana Mishra
Nov 10, 2011·Toxins·Maddalena de VirgilioMaria Serena Fabbrini
Apr 10, 2012·Drug Discovery Today·Munish PuriRaghbir C Gupta
May 9, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mayron Alves de VasconcelosRicardo Pires dos Santos
Nov 28, 2012·International Journal of Biological Macromolecules·Letícia Eulálio CastanheiraVeridiana M Rodrigues
Mar 7, 2013·Toxicon : Official Journal of the International Society on Toxinology·Fiorenzo Stirpe
Jan 1, 2014·BioMed Research International·Francisco Vassiliepe Sousa ArrudaAlexandre Holanda Sampaio
Apr 11, 2015·Journal of Immunological Methods·Keerti Jain, N K Jain

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.